| answer text |
<p>This investment is designed to benefit a range of cancer pathways. To date, over
£100 million has been allocated to replace outdated magnetic resonance imaging (MRI)
machines, of which almost £90 million included hardware able to perform multi-parametric
resonance imaging and support the diagnosis of prostate cancer. Replacing aged MRI
assets supports the prostate cancer pathway through higher quality imaging, increased
availability of MRI and reduced duplication of imaging for patients. This investment
is in addition to the routine replacement of MRI machines, which NHS Providers is
funding through its annual operational capital allocation.</p>
|
 |
